Class-Sparing Regimens for Initial Treatment of HIV-1 Infection

BACKGROUND: The use of either efavirenz or lopinavir–ritonavir plus two nucleoside reverse-transcriptase inhibitors (NRTIs) is recommended for initial therapy for patients with human immunodeficiency virus type 1 (HIV-1) infection, but which of the two regimens has greater efficacy is not known. The...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Riddler, Sharon A., Haubrich, Richard, DiRienzo, A. Gregory, Peeples, Lynne, Powderly, William G., Klingman, Karin L., Garren, Kevin W., George, Tania, Rooney, James F., Brizz, Barbara, Lalloo, Umesh G., Murphy, Robert L., Swindells, Susan, Havlir, Diane, Mellors, John W.
Formato: Artigo
Idioma:Inglês
Publicado em: 2008
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3885902/
https://ncbi.nlm.nih.gov/pubmed/18480202
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa074609
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados